Abbott Laboratories has won a legal case claiming its Similac infant formula caused the death of a baby from necrotizing ...

Abbott Laboratories backed its full-year outlook after posting higher sales in the third quarter, boosted by sales of its nutrition shakes and drinks for adults ...

Today's Research Daily features new research reports on 16 major stocks, including International Business Machines Corp. (IBM), Micron Technology, Inc. (MU) and Abbott Laboratories (ABT). These ...

Abbott Laboratories’ third quarter results met Wall Street’s expectations for both revenue and non-GAAP profit, but the ...

Abbott trimmed its earnings forecast as the Trump administration launched an investigation into medical device imports that could trigger new tariffs.

A federal judge handed Abbott Laboratories another win this week in its yearslong battle over the safety of its formulas for babies born prematurely — a decision that could have implications for ...

The court said D.B.'s parents could not meet the threshold for a product liability claim under Louisiana's Products Liability ...

The fate of hundreds of pending cases against Abbott and Mead Johnson hang in the balance with the latest dismissal.

The Abbott Laboratories logo is displayed at the company's booth during the Consumer Electronics Show (CES) on January 5, 2022 in Las Vegas, Nevada. (Photo by Patrick T. FALLON / AFP) (Photo by ...

Abbott Laboratories recently reported fourth-quarter earnings that fell 47% year over year. Declining demand for COVID-19 tests is a challenge, but multiple growth drivers could push the stock higher ...

In 2013, Abbott Labs shifted to focus on generics, medical devices, diagnostics, and nutrition. Since then, it has grown its business and become much more robust and diverse. While it has benefited ...

The HbA1c testing market presents opportunities driven by rising Type 2 diabetes cases and advancements in testing technologies. Supportive healthcare initiatives and increased awareness enhance ...